BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30043631)

  • 1. Make azoles active again: chalcones as potent reversal agents of transporters-mediated resistance in Candida albicans.
    Nim S; Baghel P; Tran-Nguyen VK; Peres B; Nguyen KA; Pietro AD; Falson P; Prasad R; Boumendjel A
    Future Med Chem; 2018 Sep; 10(18):2177-2186. PubMed ID: 30043631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulators of the Efflux Pump Cdr1p of Candida albicans: Mechanisms of Action and Chemical Features.
    Tran-Nguyen VK; Prasad R; Falson P; Boumendjel A
    Curr Med Chem; 2017; 24(30):3242-3253. PubMed ID: 28545374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model.
    Mónico A; Nim S; Duarte N; Rawal MK; Prasad R; Di Pietro A; Ferreira MU
    Bioorg Med Chem; 2017 Jul; 25(13):3278-3284. PubMed ID: 28479022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.
    Ivnitski-Steele I; Holmes AR; Lamping E; Monk BC; Cannon RD; Sklar LA
    Anal Biochem; 2009 Nov; 394(1):87-91. PubMed ID: 19577533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance.
    Keniya MV; Fleischer E; Klinger A; Cannon RD; Monk BC
    PLoS One; 2015; 10(5):e0126350. PubMed ID: 25951180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
    J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
    Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
    Sun LM; Liao K; Liang S; Yu PH; Wang DY
    J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans.
    Wang YH; Dong HH; Zhao F; Wang J; Yan F; Jiang YY; Jin YS
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3098-3102. PubMed ID: 27210436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two natural molecules preferentially inhibit azole-resistant Candida albicans with MDR1 hyperactivation.
    Shi HZ; Chang WQ; Zhang M; Lou HX
    Chin J Nat Med; 2019 Mar; 17(3):209-217. PubMed ID: 30910057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole resistance in a
    Khandelwal NK; Chauhan N; Sarkar P; Esquivel BD; Coccetti P; Singh A; Coste AT; Gupta M; Sanglard D; White TC; Chauvel M; d'Enfert C; Chattopadhyay A; Gaur NA; Mondal AK; Prasad R
    J Biol Chem; 2018 Jan; 293(2):412-432. PubMed ID: 29158264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Jatrophane Esters from Euphorbia spp. as Modulators of Candida albicans Multidrug Transporters.
    Esposito M; Nim S; Nothias LF; Gallard JF; Rawal MK; Costa J; Roussi F; Prasad R; Di Pietro A; Paolini J; Litaudon M
    J Nat Prod; 2017 Feb; 80(2):479-487. PubMed ID: 28106996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
    Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
    Sharma M; Prasad R
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4834-43. PubMed ID: 21768514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
    Bhattacharya S; Sobel JD; White TC
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5858-66. PubMed ID: 27431223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
    Prasad R; Rawal MK; Shah AH
    Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An actin depolymerizing agent 19,20-epoxycytochalasin Q of Xylaria sp. BCC 1067 enhanced antifungal action of azole drugs through ROS-mediated cell death in yeast.
    Somboon P; Soontorngun N
    Microbiol Res; 2021 Feb; 243():126646. PubMed ID: 33227681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.